Abstract
The last 15 years have witnessed a revival of interest in analogues of nucleosides following the discoveries that several of such compounds exhibit powerful antiviral effects. In this context, two compounds are of particular significance. The first of such analogues is acyclovir (1a, Zovirax) which was developed in the late seventies1 (Chart 1). Acyclovir (1a) is an analogue of 2′-deoxyguanosine of clinical importance as a drug for treatment of herpesvirus infections. The second compound is 3′-azido-3′-deoxythymidine (3b, AZT, zidovudine or Retrovir), an analogue of thymidine, and, until recently, the only approved drug for treatment of acquired immunodeficiency syndrome (AIDS). AZT (3b) was originally prepared in the sixties,2 its antiretroviral potential was recognized in the seventies,3 and it was developed as a therapeutic agent against AIDS in the eighties.4 Drugs 1a and 3b are examples of two structurally different classes of nucleoside analogues. Acyclovir (1a) belongs to a series of open-chain compounds derived by cleavage of at least one C-C bond or deletion of one or more carbon atoms of the sugar ring, whereas AZT (3b) comprises an intact furanose moiety.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H.J. Schaeffer, L. Beauchamp, P. de Miranda, G. B. Elion, D. J. Bauer, and P. Collins, 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group, Nature 272:583 (1978).
J. P. Horwitz, J. Chua, and M. Noel, Nucleosides. V. The monomesylates of l-(2′-deoxy-ß-D-lyxofuranosyl)thymine, J. Org. Chem. 29:2076 (1964).
W. Ostertag, G. Roesler, C. J. Krieg, J. Kind, T. Cole, T. Crozier, G. Gaedicke, G. Steinheider, N. Kluge, and S. Dube, Induction of endogenous virus and thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus, Proc. Natl. Acad. Sci. U.S.A. 71:4980 (1974).
H. Mitsuya, K. J. Weinhold, P. A. Furman, M. H. St. Clair, S. W. Lehrman, R. C. Gallo, D. Bolognesi, D. W. Barry, and S. Broder, 3′-Azido-3′-deoxythymidine (BWA 5090): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphoadenopathy — associated virus in vitro, Proc. Natl. Acad. Sci. U.S.A. 82:7096 (1985).
H. J. Schaeffer, S. Gurwara, R. Vince, and S. Bittner, Novel Substrate of Adenosine Deaminase, J. Med. Chem. 14:367(1971).
J. L. Kelly, L. E. Kelsey, W. R. Hall, M. P. Krochmal, and H. J. Schaeffer, Pyrimidine acyclic nucleosides. l-[(2-Hydroxyethoxy)methyl]pyrimidines as candidate antivirals, J. Med. Chem. 24:753 (1981).
H. Mitsuya, M. Matsukura, and S. Broder, Rapid in vitro systems for assessing activity of agents against HTLV-III/LAV, in: “AIDS, Modern Concepts and Therapeutic Challenges,” S. Broder, ed., Marcel Dekker, New York (1987), p. 303.
M. Baba, R. Pauwels, J. Balzarini, P. Herdewijn, and E. De Clercq, Selective inhibition of human immunodeficiency virus (HIV) by 3′-azido-2′,3′-dideoxyguanosine, Biochem. Biophys. Res. Commun. 145:1080 (1987).
R. Dolin, Antiviral chemotherapy and chemoprophylaxis, Science 227:1296 (1985).
H. Mitsuya, R. Yarchoan, and S. Broder, Molecular targets for AIDS therapy, Science 249:1533(1990).
M. M. Mansuri, J. E. Starrett, Jr., I. Ghazzouli, M. J. M. Hitchcock, R. Z. Sterzycki, V. Brankovan, T.-S. Lin, E. M. August, W. H. Prusoff, J.-P. Sommadossi, and J. C. Martin, l-(2,3-Dideoxy-ß-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent, J. Med. Chem. 32:461 (1989).
M. Baba, R. Pauwels, P. Herdewijn, E. De Clercq, J. Desmyter, and J. Vandeputte, Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxy-thymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro, Biochem. Biophys. Res. Commun. 142:128 (1987).
R. Vince and M. Hua, Synthesis and anti-HIV activity of carbocyclic 2′,3′-didehydro-2′,3′-dideoxy 2,6-disubstituted purine nucleosides, J. Med. Chem. 33:17 (1990).
V. E. Marquez and M.-I. Lim, Carbocyclic nucleosides, Med. Res. Rev.(London) 6:1 (1986).
A. Larsson, K. Stenberg, A.-C. Ericsson, U. Haglund, W. Yisak, N. G. Johansson, B. Öberg, and R. Datema, Mode of action, toxicity, pharmacokinetics, and efficacy of some antiherpes virus analogs related to buciclovir, Antimicrob. Agents Chemother. 30:598 (1986).
M. Hua, P. M. Korkowski, and R. Vince, Synthesis and biological evaluation of acyclic neplanocin A analogues, J. Med. Chem. 30:198 (1987).
S. Phadtare and J. Zemlicka, Synthesis and biological properties of 9-(trans-4-hydro-xy-2-buten-l-yl)adenine and guanine: Open-chain analogues of neplanocin A, J. Med. Chem. 30:437 (1987).
D. R. Haines, C. K. H. Tseng, and V. E. Marquez, Synthesis and biological activity of unsaturated carboacyclic purine nucleoside analogues, J. Med. Chem. 30:943 (1987).
D. R. Borcherding, S. Narayanan, M. Hasobe, J. G. McKee, B. T. Keller, and R. T. Borchardt, Potential inhibitors of S-adenosylmethionine-dependent methyltransfer-ases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adeno-sylhomocysteine hydrolase, J. Med. Chem. 31:1729 (1988).
W. T. Ashton, L. C. Meurer, C. L. Cantone, A. K. Field, J. Hannah, J. D. Karkas, R. Liou, G. F. Patel, H. C. Perry, A. F. Wagner, E. Walton, and R. L. Tolman, Synthesis and antiherpetic activity of (±)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl]-methyl]guanine and related compounds, J. Med. Chem. 31:2304 (1988).
S. Phadtare, D. Kessel, and J. Zemlicka, Unsaturated nucleoside analogues: Synthesis and antitumor activity, Nucleosides Nucleotides 8:907 (1989).
S. Phadtare, D. Kessel, T. H. Corbett, H. E. Renis, B. A. Court, and J. Zemlicka, Unsaturated and carbocyclic nucleoside analogues: Synthesis, antitumor, and antiviral activity, J. Med. Chem. 34:421 (1991).
S. Phadtare and J. Zemlicka, Allenic derivatives of nucleic acid components and their transformation products: a new class of biologically active nucleoside analogues, Nucleic Acids Res., Symp. Ser. No. 18:25 (1987).
A. Larsson, S. Alenius, N.-G. Johansson, and B. Öberg, Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine, Antiviral Res. 3:77 (1983).
S. Phadtare and J. Zemlicka, Nucleic acid derived allenols: Unusual analogues of nucleosides with antiretroviral activity, J. Am. Chem. Soc. 111:5925 (1989).
H. Mitsuya and S. Broder, Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphoadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides, Proc. Natl. Acad. Sci. U.S.A. 83:1911 (1986).
A. J. Hubert and H. Reimlinger, Base-catalysed prototropic isomerisations. Part II. The isomerisation of N-prop-2-ynyl heterocycles into N-substituted allenes and acetylenes, J. Chem. Soc. C:606 (1968).
D. Ranganathan, R. Rathi, K. Kesavan, and W. P. Singh, The demonstration of nor-mal O→N Claisen rearrangement in purines, Tetrahedron 42:43873 (1986).
A. A. Khorlin, I. P. Smirnov, S. V. Kochetkova, T. L. Tsilevich, I. L. Shchaveleva, B. P. Gottikh, and V. L. Florent′ev, Compounds similar to acyclovir. IV. Convenient method of synthesising adenallene, Bioorg. Khim. 15:530 (1989); English translation 15:291 (1990).
M. V. Kochetkova, A. V. Tsytovich, and B. I. Mitsner, A convenient approach to the synthesis of nucleic acid allene derivatives, possessing anti-HIV activity, Nucleic Acids Res., Symp. Ser. No. 24:233 (1991).
A. V. Tsytovich, M. V. Kochetkova, E. V. Kuznetsova, B. I. Mitsner, and V.I. Shvets, Acyclic nucleoside analogues. I. Development of allenic nucleoside derivatives synthesis, Bioorg. Khim. 17:1086 (1991) (in Russian).
S. Phadtare and J. Zemlicka, Synthesis of N1-(4-hydroxy-l,2-butadien-l-yl)thymine, an analogue of 3′-deoxythymidine, J. Org. Chem. 54:3675 (1989).
S. Phadtare and J. Zemlicka, unpublished experiments.
S. Hayashi, S. Phadtare, J. Zemlicka, M. Matsukura, H. Mitsuya, and S. Broder, Adenallene and cytallene: Acyclic nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro, Proc. Natl. Acad. Sci. U.S.A. 85:6127 (1988).
S. Megati, Z. Goren, J. V. Silverton, J. Orlina, H. Nishimura, T. Shirasaki, H. Mitsuya, and J. Zemlicka, R-(-)-and S-(+)-adenallene: Synthesis, absolute configuration, antiretroviral effect, and enzymic deamination, J. Med. Chem. 35:4098 (1992).
C. R. Noe, Chirale Lactole, II. Racematspaltung und enantioselektive Acetalisierung mit der 2,3,3a,4,5,6,7,7a-Octahydro-7,8,8-trimethyl-4,7-methanobenzofuran-2-yl-Schutzgruppe, Chem. Ber. 115:1591 (1982).
S. Phadtare and J. Zemlicka, Allenic derivatives of nucleic acid bases — new acyclic nucleoside analogues with antiretroviral activity, Nucleic Acids Res., Symp. Ser. No. 20:39 (1988).
P. Van Roey, E. W. Taylor, C. K. Chu, and R. F. Schinazi, Correlation of molecular conformation and activity of reverse transcriptase inhibitors, Ann. N. Y. Acad. Sci. 616:29 (1990).
E. W. Taylor, P. Van Roey, R. F. Schinazi, and C. K. Chu, A stereochemical rationale for the activity of anti-HIV nucleosides, Antiviral Chem. Chemother. 1:163 (1990).
J. March, “Advanced Organic Chemistry”, McGraw-Hill, New York, 1977, p. 24.
W. Runge, Stereochemistry of allenes, in: “The Chemistry of the Allenes”, Vol. 3, S. R. Landor, ed., Academic Press, New York, 1982, p. 579.
N. N. H. Teng, M. S. Itzkowitz, and I. Tinoco, Jr., Calculation of the rotational strength of mononucleosides, J. Am. Chem. Soc. 93:6257 (1971).
W. Runge, Spectroscopic properties of allenes, in: “The Chemistry of the Allenes”, Vol. 3, S. R. Landor, ed., Academic Press, New York, 1982, p. 777.
R. Gompper and U. Wolf, Synthesen und Reaktionen electronarmer Allene, Liebigs Ann. Chem. 1388 (1979).
S. Phadtare and J. Zemlicka, Synthesis of (Z)-and (E)-N9-(4-hydroxy-l-buten-l-yl)-adenine — new unsaturated analogues of adenosine, Tetrahedron Lett.31:43 (1990).
J. R. Wiersig, A. N. H. Yeo, and C. Djerassi, Mass spectrometry in structural and stereochemical studies. 247. Electron-impact induced fragmentation of allenes, J. Am. Chem. Soc. 99:532 (1977).
“The Chemistry of the Allenes11, Vol. 2, S. R. Landor, ed., 1982.
R. Engel, “Synthesis of Carbon-Phosphorus Bond”, CRC Press, Boca Raton, Florida, 1988, p. 21.
Ref. 48, p. 7.
“Nucleotide Analogues as Antiviral Agents”, ACS Symposium Series 401, J. C. Martin, ed., American Chemical Society, Washington, D. C, 1989.
S. Phadtare and J. Zemlicka, Unsaturated analogues of acyclic nucleoside phosphonates: An unusual Arbuzov reaction with unactivated triple bond, Nucleosides Nucleotides 10:275 (1991).
S. Megati, S. Phadtare, and J. Zemlicka, Unsaturated phosphonates as acyclic nucleotide analogues. Anomalous Michaelis-Arbuzov and Michaelis-Becker reactions with multiple bond systems, J. Org. Chem. 57:2320 (1992).
M. Huché and P. Cresson, Réactions sigmatropiques d’ordre (2,3) au niveau d’un atome de phosphore, Bull. Soc. Chim. Fr. No. 3-4:800 (1975).
A. J. Kirby and S. G. Warren, “The Organic Chemistry of Phosphorus”, Elsevier, New York, 1967, p.39.
H. Mitsuya and S. Broder, Strategies for antiviral therapy in AIDS, Nature325:773 (1987).
S. Hayashi, S. Phadtare, J. Zemlicka, M. Matsukura, H. Mitsuya, and S. Broder, Adenallene and cytallene, two novel acyclic nucleoside derivatives active against human immunodeficiency virus (HIV) in T-cells and monocytes/macrophages in vitro: Further characterization of anti-viral and cytotoxic activity, in: “Mechanisms of Action and Therapeutic Applications of Biologicals in Cancer and Immune Deficiency Disorders”, Alan R. Liss, Inc., 1989, p. 371.
B. A. Larder, B. Chesebro, and D. D. Richman, Susceptibilities of zidovudine-susceptible and-resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay, Antimicrob. Agents Chemother. 34:436 (1990).
M. M. Mansuri, V. Farina, J. E. Starrett, Jr., D. A. Benigni, V. Brankovan, and J. C. Martin, Preparation of the geometric isomers of DDC, DDA, D4C and D4T as potential anti-HIV agents, Bioorg. Med. Chem. Lett. 1:65(1991).
S. Hayashi, M. Matsukura, H. Mitsuya, and S. Broder, unpublished results.
C.-H. Kim, V. E. Marquez, S. Broder, H. Mitsuya, and J. S. Driscoll, Potential AIDS drugs. 2′,3′-Dideoxycytidine analogues, J. Med. Chem. 30:862 (1987).
R. Pauwels, M. Baba, J. Balzarini, P. Herdewijn, J. Desmyter, M. J. Robins, R. Zhou, D. Madej, and E. De Clercq, Investigations on the anti-HIV activity of 2′,3′-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2′,3′-dideoxy-riboside, Biochem. Pharmacol. 37:1317 (1988).
M. A. Johnson, G. Ahluwalia, M. C. Connelly, D. A. Cooney, S. Broder, D. G. Johns, and A. Fridland, Metabolic pathways for the activation of the antiretroviral agent 2′,3′-dideoxyadenosine in human lymphoid cells, J. Biol. Chem. 263:15354 (1988).
G. I. Birnbaum, M. Cygler, and D. Shugar, Conformational features of acyclonucleo-sides: structure of acyclovir, an antiherpes agent, Can. J. Chem. 62:2646 (1984).
P. Van Roey, J. M. Salerno, C. K. Chu, and R. F. Schinazi, Correlation between preferred sugar conformation and activity of nucleoside analogues against human immunodeficiency virus, Proc. Natl. Acad. Sci. U.S.A. 86:3929 (1989).
C. K.-H. Tseng, V. E. Marquez, G. W. A. Milne, R. J. Wysocki, Jr., H. Mitsuya, T. Shirasaki, and J. S. Driscoll, A ring-enlarged oxetanocin A analogue as an inhibitor of HIV infectivity, J. Med. Chem. 34:343 (1991).
C. K. Chu, S. K. Ahn, H. O. Kim., J. W. Beach, A. J. Alves, L. S. Jeong, Q. Islam, P. Van Roey, and R. F. Schinazi, Asymmetric synthesis of enantiomerically pure (-)-(1′R,4′R)-dioxolane-thymine and its anti-HIV activity, Tetrahedron Lett. 32: 3791 (1991).
Y.-C. Liaw, Y.-G. Gao, V. E. Marquez, and A. H.-J. Wang, Molecular structures of two new anti-HIV nucleoside analogs: 9-(2,3-dideoxy-2-fluoro-ß-D-rhreo-pento-furanosyl)adenine and 9-(2,3-dideoxy-2-fluoro-ß-D-rthreo-pentofuranosyl)hypo-xanthine, Nucleic Acids Res. 20:459 (1992).
S. Eriksson, B. Kierdaszuk, B. Munch-Petersen, B. Öberg, and N. G. Johansson, Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogues, Biochem. Biophys. Res. Commun. 176:586 (1991).
B. Kierdaszuk, C. Bohman, B. Ullman, and S. Eriksson, Substrate specificity of human deoxycytidine kinase toward antiviral 2′,3′-dideoxynucleoside analogues, Biochem. Pharmacol. 43:197 (1992).
D. A. Cooney, G. Ahluwalia, H. Mitsuya, A. Fridland, M. Johnson, Z. Hao, M. Dalai, J. Balzarini, S. Broder, and D. G. Johns, Initial studies on the cellular pharmacology of 2′,3′-dideoxyadenosine, an inhibitor of HTLV-III infectivity, Biochem. Pharmacol. 36:1765 (1987).
D. Kessel, unpublished results.
R. V. Joshi, D. Kessel, T. H. Corbett, and J. Zemlicka, Ynamines derived from nucleic acids bases: synthesis, reactivity and biological activity, J. Chem. Soc., Chem. Commun. No. 6:513 (1992).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zemlicka, J. (1993). Allenols Derived from Nucleic Acid Bases — A New Class of Anti-HIV Agents: Chemistry and Biological Activity. In: Chu, C.K., Baker, D.C. (eds) Nucleosides and Nucleotides as Antitumor and Antiviral Agents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2824-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2824-1_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6221-0
Online ISBN: 978-1-4615-2824-1
eBook Packages: Springer Book Archive